Member Info for Iwant

Https://shab.ch/#!/search/publications/detail/4c9ae79b-8cc6-45f9-98db-b7c61dc9bbb5

@CuriousInvester6

Follow the link in my post to the shab...

@ac123

This is the central question, not so easy to answer. In my opinion, at least certain key persons with the right technical knowledge and overview of former ADAM would be necessary.

The proximity to CERN with its bunker facilities might be necessary. Whether a complete relocation to Daresbury is feasible would require analysis. However, to make a final judgment, these persons would need to be available.

Establishing a new company, ADAMx, would not be a problem in Switzerland. It could then start anew, debt-free. It wouldn't be the first company to do so.

But was the BoD far-sighted enough in the past, and are they capable of shouldering this?

All over now, baby blue:

https://www.gov.uk/employment-tribunal-decisions?keywords=oncotherapy

And until now, no word from the BoD

Incompetent:

https://shab.ch/#!/search/publications/detail/62c56509-42d5-452d-898c-5a85a16fb927

Basil,

Electron beam therapy and proton beam therapy are distinct modalities used in radiation treatment. Proton beam therapy is particularly known for utilizing the Bragg Peak effect, which allows for maximum energy delivery at a controlled depth, minimizing damage to surrounding tissues. Just Google.

FLASH (Fast Linear Accelerator System for Hadrons) therapy is an innovative approach that delivers an ultra-high dose of radiation in a single pulse. This technique can be applied using both electrons and protons, and is designed to maximize the therapeutic effect while minimizing damage to healthy tissue. The LIGHT system developed by AVO is an example of technology that can deliver FLASH therapy.

A LINAC refers to a Linear Accelerator, which is used to accelerate particles along a straight path, as opposed to circular accelerators like cyclotrons or synchrotrons. LINACs are versatile and can be used to accelerate various types of particles, including electrons and protons. AVO's innovation lies in adapting LINAC technology for proton therapy, which offers several benefits. These include the ability to rapidly adjust beam energies without loss of intensity, which is crucial for targeting tumors at varying depths with precision. Moreover, linear accelerators for protons can be more cost-effective compared to traditional circular accelerators.

So, the CHUV plan is technically not comparable with what AVO has in the pipeline. But if AVO would be able to deliver, I'm sure the CHUV would think about to use this much better technology.

Lost chance.

The moratorium on restructuring for A.D.A.M has now expired. We will see if the BoD did their job.

Tomorrow, children, something will happen!

Tomorrow we will be ???!

What a delight, what a life

There will be in our office!

There are certainly former employees of AVO and ADAM here who know exactly what is going on.

The last major investment of 80 million until the breakthrough is certainly not just for a few small cosmetic works. The last phase is always the most critical and always underestimated.

But that was no different with Medaustron, on the contrary.

I don't think there will be much news until the end of March, because that's when the question of ADAM's survival comes up. Perhaps the delay is even because of that.

The China issue may be more realistic than is currently believed.

A major investor comes from China (a pharmaceutical company, which has secured the distribution rights in China) and P-Cure, the previous supplier of the patient positioning system inclusive Philips CT, is financially linked to China, with a company that is already active in this field. P-Cure had massive financial problems and got involved with this Chinese company. Perhaps someone else here can explain more details.

In any case, P-Cure was financially reorganised but at the same time became a competitor.

The LINAC accelerator technology, which is much cheaper and better at the same time, is still missing.

The BoD also has more than just share packages, which may mean that other priorities play a role. Odey started a sold out of their shares (everyone knows why), which caused the last drop-down of the SP. No-one knows what's happening actually.

As the BoD does everything behind closed doors, there is plenty of room for speculation.

I think it's time that Nicolas Serandour lifts now the secrets that everyone knows where we are.

@PM44

Yes, I have invested and not a little. Because I know the technology and know that the system can work very well. There are no more technical showstoppers. The system is doomed to be a success once the prototype in Daresbury has been completed and a tumour or water phantom can be irradiated with it. The final financial investment is missing and that is solely the fault of the BoD and there the CEO as he is responsible for this task.

A typical mistake is to underestimate the time needed for development and the certifications required in medical technology. The 230 MeV was an important milestone, the proof that the engine works. But before the "aircraft can fly safely", everything else has to be right. These are no longer unsolvable problems, that's sure, but it is a lot of work. And it was precisely for these tasks that time and therefore money ran out. On the other hand, you often can't tell investors the real development times because they don't have the patience to wait due to today's expectations that everything has to make a lot of profit very quickly.

A proton therapy system is the largest and most complex medical device in the world. The market for such systems is immense and so are the profits after market launch. But this requires investors who understand this and have the patience. And I think that's what the BoD is not ideal for to find them.

Michael Sinclair, former CEO, once said that he would never have agreed to lead this project if CERN had told him how big it would really be. But then, as it progressed and he realised it, he understood also the potential behind it. There are people I trust to convince investors for such large-scale projects. Michael Sinclair certainly has a good charisma for it and I hope he's still in an active role. Another person, not at AVO, but involved in high tech complex projects is Bertrand Picard, who I would have tried to get into the BoD. He is even not fare from CERN. I had the opportunity to meet him in person in Payern. He has the necessary charisma and vision plus the technology interest for such large-scale projects, which ultimately benefit the general public.

ADAM recently moved to a building not far from the previous one in Meyrin. Even if the expenses are lower, they have to be paid. The 50kCHF will certainly be needed to rent the premises etc

and thus for the survival of ADAM.

What's that "Harley Street ready for installation"? The prototype in Daresbury is not even finished yet.

Your "Cleveland Clinic" posts are copies of outdated publications?

You must chat with staff members. This is not on public accessible documents with exception of planned staff reduction.

I never said that Cosy has a problem. They are certainly interested to take over the company or at least a part of it for low costs.

My info is real.

AVO has about 100 employees, which are on Linkedin plus Cosy Labs. Not complicate to get those information. They pay salaries but delayed. Several left the company like the engineering director others were asked to leave.

Cosy did it right as shares cannot be refused to be transferred. Cash yes.

AVO now has to postpone salary payments for the third time and has given instructions to work remotely with immediate effect. You can imagine what this could mean yourself.

Cosy knew exactly what the financial situation was, as they had been working with AVO in Geneva for years, so they took precautions. It is not the first time that suppliers have not been paid.